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Evaluation of serum levels of sirtuin-1 in lung cancer  
Abstract 
 
Background: Sirtuin-1 is a protein from the family of sirtuins that has been 
implicated in inflammaging and oxidative stress in cancer patients. 
 
Aim: The aim of this study was to investigate the serum level of Sirtuin-1 and its 
relation with quality of life in lung cancer.  
 
Methods‌  & material: Sirtuin-1 levels were measured in 30 male with lung 
cancer and 50 healthy men. The two groups were matched for age. The difference 
between the serum levels of Sirtuin-1 between the two groups and its relationship 
with other clinical parameters were evaluated. Data were analyzed by independent 
T-test and Spearman correlation and P <0.05 was considered as significant. 
 
Results: Sirtuin-1 levels were significantly lower in the patient group in 
comparison with healthy group (P <0.001). There was also a significant 
relationship between serum level of Sirtuin-1 and quality of life according to 
Karnofsky scale (P = 0.001 r = 0.558), arterial oxygen saturation (P = 0.009 r = 
0.470) and smoking history (P=0.003 r = - 0.330). Also, the serum levels of 
Sirtuin-1 were significantly lower in adenocarcinoma than that in squamous cell 
carcinoma or small cell lung cancer (p = 0.001). 
 
Conclusion: In this study, serum levels of sirtuin-1 were lower in patients with 
lung cancer. In addition, there was a correlation between serum levels of sirtuin-1 
and patients' quality of life (according to Karnofsky scale), hypoxia and smoking 
history. Therefore, decreased serum sirtuin-1 levels in lung cancer reflect the cell 
aging process and correlate with poor quality of life. 
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